Zoetis Inc (ZTS)
176.71
+1.04
(+0.59%)
USD |
NYSE |
Nov 21, 16:00
176.71
0.00 (0.00%)
After-Hours: 20:00
Zoetis Price to Book Value: 15.23 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 15.14 |
November 19, 2024 | 15.13 |
November 18, 2024 | 15.21 |
November 15, 2024 | 15.10 |
November 14, 2024 | 15.05 |
November 13, 2024 | 15.26 |
November 12, 2024 | 15.00 |
November 11, 2024 | 15.18 |
November 08, 2024 | 15.24 |
November 07, 2024 | 15.02 |
November 06, 2024 | 14.69 |
November 05, 2024 | 15.11 |
November 04, 2024 | 15.10 |
November 01, 2024 | 15.68 |
October 31, 2024 | 15.41 |
October 30, 2024 | 15.77 |
October 29, 2024 | 15.64 |
October 28, 2024 | 15.77 |
October 25, 2024 | 15.53 |
October 24, 2024 | 15.66 |
October 23, 2024 | 16.30 |
October 22, 2024 | 16.35 |
October 21, 2024 | 16.34 |
October 18, 2024 | 16.67 |
October 17, 2024 | 16.48 |
Date | Value |
---|---|
October 16, 2024 | 16.77 |
October 15, 2024 | 16.60 |
October 14, 2024 | 16.62 |
October 11, 2024 | 16.40 |
October 10, 2024 | 16.42 |
October 09, 2024 | 16.41 |
October 08, 2024 | 16.16 |
October 07, 2024 | 16.16 |
October 04, 2024 | 16.39 |
October 03, 2024 | 16.48 |
October 02, 2024 | 16.60 |
October 01, 2024 | 16.77 |
September 30, 2024 | 16.86 |
September 27, 2024 | 17.77 |
September 26, 2024 | 17.78 |
September 25, 2024 | 17.47 |
September 24, 2024 | 17.67 |
September 23, 2024 | 17.66 |
September 20, 2024 | 17.57 |
September 19, 2024 | 17.63 |
September 18, 2024 | 17.92 |
September 17, 2024 | 17.85 |
September 16, 2024 | 17.72 |
September 13, 2024 | 17.43 |
September 12, 2024 | 17.40 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.11
Minimum
Nov 03 2022
26.34
Maximum
Sep 02 2020
19.11
Average
18.48
Median
Price to Book Value Benchmarks
Pfizer Inc | 1.543 |
Regeneron Pharmaceuticals Inc | 2.790 |
Vertex Pharmaceuticals Inc | 7.420 |
Alnylam Pharmaceuticals Inc | 984.20 |
Biomarin Pharmaceutical Inc | 2.233 |
Price to Book Value Related Metrics
PE Ratio | 33.22 |
PS Ratio | 8.826 |
PEG Ratio | 4.086 |
Price to Free Cash Flow | 35.00 |
Price | 176.71 |
Earnings Yield | 3.01% |
Market Cap | 79.73B |
PEGY Ratio | 3.645 |
Operating PE Ratio | 24.21 |
Normalized PE Ratio | 31.57 |